Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Clinical Study of Chemoradiation Followed by VIPD in Nasal Natural Killer (NK)/T-cell Lymphoma
Phase 2
Completed
- Conditions
- First Posted Date
- 2007-01-05
- Last Posted Date
- 2009-10-21
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00418535
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Prevalence of Salivary Hypofunction in Patients With Globus Pharyngeus
- First Posted Date
- 2006-09-28
- Last Posted Date
- 2010-07-28
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 340
- Registration Number
- NCT00381771
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-09-11
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 55
- Registration Number
- NCT00374699
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Sequentially Combined Vitrectomy, IVTA and Macular Focal Laser Photocoagulation for Diabetic Macular Edema
Phase 1
Completed
- Conditions
- First Posted Date
- 2006-09-04
- Last Posted Date
- 2006-09-04
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00371410
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Phase 4
Completed
- Conditions
- First Posted Date
- 2006-06-13
- Last Posted Date
- 2008-11-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT00336531
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
L-Ascorbic Acid Depletion to Treat Acute Myeloid Leukemia and Myelodysplastic Syndromes
Phase 2
Suspended
- Conditions
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2006-10-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00329498
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Efficacy Study of Induction Chemotherapy Before Surgery in Operable Non-small Cell Lung Cancer
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2010-08-27
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT00329472
Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-05-16
- Last Posted Date
- 2015-06-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 434
- Registration Number
- NCT00326378
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Phase III Randomized Trial of Adjuvant XP Chemotherapy and XP/RT for Resected Gastric Adenocarcinoma
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2006-05-10
- Last Posted Date
- 2011-11-09
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 458
- Registration Number
- NCT00323830
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Phase II Study of Simvastatin Plus Irinotecan, Fluorouracil, and Leucovorin(FOLFIRI) for Metastatic CRC
Phase 2
Completed
- Conditions
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2012-02-02
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT00313859
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath